Novo Nordisk and Vivtex partner in deal worth up to $2.1bn
The companies aim to develop next-generation oral medicines for obesity and diabetes
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek
The board will support the CGT Catapult in identifying and removing barriers to the widespread adoption of advanced therapies
GSK to acquire 35Pharma for $950m including a potential drug for pulmonary hypertension
PH has a five‑year survival rate of only around 50% and affects up to 82 million people worldwide
Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo
This is the first approved treatment option in the UK for patients with non-segmental vitiligo
Novo Nordisk and Vivtex partner in deal worth up to $2.1bn
The companies aim to develop next-generation oral medicines for obesity and diabetes
Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026
The conference will take place from 6 to 7 October 2026 in Copenhagen, Denmark
Intelligence
The race to explore and harness GenAI in healthcare
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read More
Communication breakdown
Why soft skills are more important than ever in life sciences
Read More
Medicine shortages strike again – can radio-frequency identification technology help?
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read More
Pandemic readiness is now a financial risk test – and the UK must treat it that way
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More
Designing healthcare AI that works for every patient
As generative AI becomes more embedded in clinical decision-making, ensuring safety, accuracy and relevance is critical
Read More
Oral health and systemic disease: why they may be more closely linked than we thought
P. gingivalis, a type of bacteria found in the mouth, is linked to autoimmune diseases like rheumatoid arthritis
Read More
Blogs
Latest
From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction
February 26, 2026 | Impetus Digital|3d, Advisory board, Digital engagement, HCP education, HCP engagement, Holovision, KOL Engagement, MSL enablement, Pharma trends, Virtual Engagement, ai avatar, excape room, free webinar, gamification, invetigator meeting, micromodules, pharma webinar, webinar
Stop pushing content at a burnt-out audience and start creating “Digital Magnetism.” Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the …
Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden
February 25, 2026 | Medscape Education|Wold Health Assembly, World Economic Forum, rare disease
Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families …
T40: when a number is not just a number
February 23, 2026 | Grace Communications|agency
Proud to be ranked 3rd among the Top 10 UK-focused agencies, along with other categories, Grace Communications finds inspiration in being included in PMLive’s Top …
New Cuttsy+Cuttsy research shows why site support matters more than ever
February 23, 2026 | Cuttsy + Cuttsy|Participant engagement, Site staff, clinical trials, patient engagement, research
Cuttsy+Cuttsy’s upcoming report, ‘The site factor: Where protocol meets practice in clinical trials’, delves into the critical role of site staff in clinical research, offering …
#ShortenTheJourney
February 18, 2026 | Medscape Education|Education, Real World Outcomes, rare disease
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. …
Why patient engagement must come first in rare disease trials
February 23, 2026 | Cuttsy + Cuttsy|clinical trials, patient engagement, rare disease
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients’ lives to …
Winning in Pharma: the power of early strategic planning with patients
February 17, 2026 | Amiculum|Early strategic planning, Launch strategy, Patient partnership, Pharma Strategy, patient engagement
By Zoë van Helmond
Turn payer insights into impact with omnichannel engagement in market access
February 17, 2026 | Amiculum|Market Access, omnichannel
By Betty Charleshouse
What HCPs want from digital pharma in 2026: The value gap
February 16, 2026 | Graphite Digital|HCP Digital Engagement, HCP experience, Healthcare Digital Experience, Life Sciences Innovation, Pharma Digital Strategy
We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the …
How can pharma build genuine partnerships with patient communities?
January 19, 2026 | Amiculum|patient advocacy, patient engagement
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines …